In 2023, diuretic medicine sales in Canada stood at $7.4 USD per capita. Forecasted data from 2024 to 2028 show a gradual increase, moving from $7.5 USD per capita in 2024 to $8 USD per capita in 2028. This marks a compound annual growth rate (CAGR) of approximately 1.6%. Year-on-year growth is consistent, averaging around 0.5%, indicating a steady market environment.

Future trends to watch for include potential impacts from demographic shifts such as an aging population, increased prevalence of conditions requiring diuretics, healthcare policy changes, and innovation in alternative therapies that may affect demand for diuretic medicines.

Download as XLS

More about Diuretic Industry 2026-2030